S&P 500   3,901.36
DOW   31,261.90
QQQ   288.68
S&P 500   3,901.36
DOW   31,261.90
QQQ   288.68
S&P 500   3,901.36
DOW   31,261.90
QQQ   288.68
S&P 500   3,901.36
DOW   31,261.90
QQQ   288.68
LON:SENS

Sensyne Health (SENS) Share Forecast, Price & News

GBX 1.23
-0.15 (-10.91%)
(As of 05/20/2022 03:48 PM ET)
Add
Compare
Today's Range
1.20
1.38
50-Day Range
1.20
11.70
52-Week Range
1
161.75
Volume
2.57 million shs
Average Volume
3.74 million shs
Market Capitalization
£2.04 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
N/A
30 days | 90 days | 365 days | Advanced Chart
Receive SENS News and Ratings via Email

Sign-up to receive the latest news and ratings for Sensyne Health and its competitors with MarketBeat's FREE daily newsletter.

Sensyne Health logo

About Sensyne Health

Sensyne Health plc is a healthcare technology company that creates value from accelerating the discovery and development of new medicines and improving patient care through the analysis of real-world evidence from large databases of anonymised patient data in collaboration with NHS Trusts. These anonymised patient data are ethically sourced in that any analysis of anonymised patient data (and hence the Company's access to it) must be pre-approved for each programme on a case-by-case basis by the relevant NHS Trusts. This is to ensure that the purpose of the anonymisation and the proposed analysis are subject to appropriate ethical oversight and information governance, including conformance with NHS principles, UK data protection law and applicable regulatory guidance. Sensyne Health is an early signatory to the Department of Health and Social Care's ‘Initial Code of Conduct for data-driven health and care technology'.

Headlines

See More Headlines

Industry, Sector and Symbol

Industry
Health Information Services
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
70
Year Founded
N/A

Sales & Book Value

Annual Sales
£7.81 million
Cash Flow
GBX 4 per share
Book Value
GBX 20.30 per share

Profitability

Pretax Margin
N/A

Debt

Price-To-Earnings

Miscellaneous

Free Float
N/A
Market Cap
£2.04 million
Optionable
Optionable

MarketRank

Overall MarketRank

1.83 out of 5 stars

Analyst Opinion: 3.5Community Rank: 5.0Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.6 5 -4 -3 -2 -1 -













Sensyne Health (LON:SENS) Frequently Asked Questions

Is Sensyne Health a buy right now?

3 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Sensyne Health in the last twelve months. There are currently 3 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" Sensyne Health stock.
View analyst ratings for Sensyne Health
or view top-rated stocks.

What price target have analysts set for SENS?

3 Wall Street analysts have issued 12-month price objectives for Sensyne Health's stock. Their forecasts range from GBX 310 to GBX 349. On average, they anticipate Sensyne Health's stock price to reach GBX 336 in the next twelve months. This suggests a possible upside of 27,328.6% from the stock's current price.
View analysts' price targets for Sensyne Health
or view top-rated stocks among Wall Street analysts.

What other stocks do shareholders of Sensyne Health own?
What is Sensyne Health's stock symbol?

Sensyne Health trades on the London Stock Exchange (LON) under the ticker symbol "SENS."

How do I buy shares of Sensyne Health?

Shares of SENS and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

What is Sensyne Health's stock price today?

One share of SENS stock can currently be purchased for approximately GBX 1.23.

How much money does Sensyne Health make?

Sensyne Health has a market capitalization of £2.04 million and generates £7.81 million in revenue each year.

How many employees does Sensyne Health have?

Sensyne Health employs 70 workers across the globe.

What is Sensyne Health's official website?

The official website for Sensyne Health is www.sensynehealth.com.

How can I contact Sensyne Health?

The company can be reached via phone at 44 3300 581845.

This page was last updated on 5/23/2022 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.